Medicines committee denies applications for wider access to ibuprofen

+Print Archive
News

Medicines committee denies applications for wider access to ibuprofen

Jonathan
Chilton Towle
There will be no change to the classifications of ibuprofen 300mg powder form, and 400mg tablets
There will be no change to the classifications of ibuprofen 300mg powder form, and 400mg tablets

Two bids to widen access to higherstrength doses of ibuprofen have been declined by the Medicines Classification Committee.

At its meeting on 11 May, the MCC discussed an application by Reckitt Benckiser New Zealand, the manufacturer of Nurofen 400 Double Strength, to have